Epidemiological studies show that both tobacco use and alcohol Boulevard, Houston, TX 77030, USA consumption are the major risk factors for SCCHN (2). 3 To whom correspondence should be addressed However, only a small fraction of smokers or alcohol users Email: qwei@mdanderson.org develop SCCHN, suggesting that genetic susceptibility and A G→A polymorphism (G870A) in exon 4 of the cyclin D1
develop SCCHN, suggesting that genetic susceptibility and A G→A polymorphism (G870A) in exon 4 of the cyclin D1 interactions between genetic and environmental factors play (CCND1) gene creates an alternative splice site in its important roles in the etiology of SCCHN (3).
mRNA, encoding a protein with an altered C-terminal
Because carcinogenesis of the head and neck involves domain. It has been suggested that DNA damage in cells abnormalities in carcinogen metabolism, DNA repair and cell with the A allele bypasses the G 1 /S checkpoint of the cell cycle control or apoptosis (4-7), polymorphisms of genes cycle more easily than damage in cells without the A allele.
involved in these pathogenic pathways are good candidates Because CCND1 plays a critical role in cell cycle control for investigations of genetic susceptibility. Normal cell cycle and reduced DNA repair capacity is associated with an control ensures a rest in the cell cycle allowing DNA damage increased risk for squamous cell carcinoma of the head in a cell to be repaired before the cell begins the process of and neck (SCCHN), we hypothesize that this CCND1 growth, mitosis and division (8-10). The transition through polymorphism modulates individual susceptibility to G 1 to S phase of the cell cycle is regulated by cyclin-dependent SCCHN. To test this hypothesis we evaluated the frequency kinases (CDKs) (8). Cyclin D1 (CCND1) is a key regulatory of the polymorphism in a hospital-based case-control study protein in this process, playing a critical role in the transition of 233 newly diagnosed SCCHN patients and 248 nonfrom G 1 to S phase of the cell cycle (9). The activity of cancer controls. The cases and controls were frequency CCND1 reaches a maximum during G 1 phase; and is associated matched by age (⍨5 years), sex and tobacco use. All with CDK4 and CDK6 in mid to late G 1 phase, therefore, it subjects were non-Hispanic whites. We found that the A is one of the major cyclins involved in this transition (8). allele frequency was slightly higher in the cases (0.485) than Alterations in CCND1 are thought to be involved in carcinoin the controls (0.425), but the difference was borderline genesis because activation of CCND1 and overexpression of statistically significant (P ⍧ 0.064). The frequencies of the CCND1 have been found in a variety of tumors, including CCND1 AA, GA and GG genotypes were 23.6, 49.8 and those of the breast, head and neck, esophagus, larynx and lung 26.6%, respectively, in cases and 16.5, 52.5 and 31.5%, (11-13). respectively, in controls. Multivariate logistic regression
Betticher and colleagues (14) identified a single base pair analysis adjusting for age (in years), sex, smoking and polymorphism (G870A) in CCND1. This polymorphism does alcohol use was performed to calculate odds ratios (OR) not lead to an amino acid change, but the variant nucleotide and 95% confidence intervals (CI). Compared with the interferes with splicing from exon 4 to exon 5 because of its wild-type CCND1 GG, the CCND1 A G genotype was unique localization within a conserved splice donor region. It associated with a non-significantly increased risk (adjusted has been postulated that the A allele enhances alternative gene OR 1.15, 95% CI 0.75-1.76), but the CCND1 AA genotype splicing, leading to an altered protein that does not contain was associated with a significantly increased risk (adjusted the sequences involved in protein turnover. Therefore, it has OR 1.77, 95% CI 1.04-3.02) for SCCHN. Results from a been suggested that DNA damage in cells from subjects with trend test using a logistic regression model were statistically the A allele may bypass the G 1 /S checkpoint of the cell cycle significant (P ⍧ 0.044). Among the cases the mean age of control mechanism more easily than damage in cells not onset was 59.0, 56.8 and 55.5 years for the GG, GA and carrying the polymorphism (15). AA genotypes, respectively. In the stratification analysis Because CCND1 plays a critical role in cell cycle control the CCND1 AA variant genotype was associated with a >3-and there is evidence that reduced DNA repair capacity is fold increased risk in individuals who were ഛ50 years old associated with increased risk of SCCHN (16) .0 0.005 subjects for the current analysis; the controls were frequency matched to the patients by age (Ϯ5 years), sex, ethnicity and smoking status. The participation a Two-sided χ 2 test. rate among eligible controls was 73.3%. Each eligible subject was interviewed to elicit data on age, sex, ethnicity, smoking status and alcohol consumption (prior to the onset of disease for the cases). After informed consent was CCND1 genotype was recorded as a dummy variable. For stratification analysis obtained each subject also donated 30 ml of blood, which was collected and by age, cases aged 50 or younger were considered as having an early age of stored in heparinized tubes. The research protocol was approved by our onset. A trend test for the number of A alleles was also performed using a Institutional Review Board. logistic regression model. All the statistical analyses were performed using Genotyping Statistical Analysis System software V.6.12 (SAS Institute, Cary, NC). From each blood sample, a leukocyte cell pellet was obtained from the buffy coat by centrifugation of 1 ml of whole blood. The cell pellet was used for
Results
DNA extraction. The Qiagen DNA Blood Mini Kit (Qiagen, Valencia, CA) was used according to the manufacturer's instructions to obtain genomic DNA.
The analysis included 233 cases and 248 controls, all of whom
The DNA purity and concentration were determined by spectrophotometric were non-Hispanic whites. As shown in Table I , the cases and measurement of absorbance at 260 and 280 nm. controls were adequately matched by age, sex and smoking PCR-single-strand conformation polymorphism (SSCP) analysis was used to genotype the CCND1 polymorphism in exon 4. For PCR the primers were status. However, alcohol use, which was not a matching 5Ј-TACTACCGCCTCACACGCTTCC-3Ј (sense) and 5Ј-TTG 2 GCACvariable, was significantly more common in cases than in CAGCCTCGGCATTTC-3Ј (antisense), which generate a 138 bp fragment. controls (P 0.005 Ͻ 0.01). The distributions of CCND1 These fragments were amplified in 25 µl of reaction mixture containing genotype and allele frequencies in SCCHN patients and con-50 ng genomic DNA, 6.25 pmol each primer, 1ϫ PCR buffer (50 mM KCl, 10 mM Tris-HCl, pH 9.0 at 25°C, and 0.1% Triton X-100), 1.5 mM MgCl 2 , trols are shown in Table II 26.6%, respectively, in cases and 16.5, 52.0 and 31.5%, mutation detection enhancement gel (FMC BioProducts, Rockland, ME) for electrophoresis at 35 W for 4 h. After electrophoresis the gels were dried and respectively, in controls (Table II) . Although the CCND1 AA imaged by exposure to X-ray film. The band shift patterns were visualized genotype was more frequent in cases than in controls, the by autoradiography. Figure 1 shows representative SSCP band shifts. Based difference in genotype distribution was not statistically signion these band shift patterns subjects were divided into groups for the three ficant (P ϭ 0.129).
CCND1 genotypes, GG, GA and AA.
To evaluate the association between the CCND1 polymorph- using a logistic regression model showed that the effects of had reported drinking alcoholic beverages at least once a week Ͼ1 year previously (before diagnosis or interview) were defined as ever drinkers; in genotype on the OR were statistically significant (P ϭ 0.044) this group those who had quit drinking Ͼ1 year before diagnosis were defined after adjustment for age (in years), sex, smoking status and as former drinkers and the others as current drinkers. The odds ratios (ORs) alcohol use (Table II) .
and their 95% confidence intervals (CIs) for the CCND1 genotype were mean ages of cancer onset for patients with the GG, GA and and CCND1 controls the transition from G 1 to S phase. The AA genotypes were 59.0, 56.8 and 55.5 years, respectively, CCND1 gene is located at 11q13 and can act as an oncogene but the differences were not significant (data not shown).
(17-19); it is often overexpressed in tumor cells. In cultured However, in the younger subgroup (age ഛ50years) the OR cells a cDNA clone of the CCND1 gene contributes to cell was 3.18 (95% CI 1.19-8.46) for the AA genotype after transformation by complementing a defective adenovirus E1A adjustment for sex, smoking and alcohol status. Females oncogene. Rimokh et al. (20) showed that rearrangement and exhibited an elevated risk (3.57, 95% CI 1.26-10.0) associated overexpression of CCND1 (BCL1/PRAD1) are consistent with the AA genotype, but this was not evident for men (OR features of t(11q13)-bearing B lymphoid tumors (particularly 1.37, 95% CI 0.73-2.56). In addition, significantly elevated mantle cell lymphoma). Its deregulation is thought to perturb ORs associated with the AA genotype were evident in those the G 1 /S transition of the cell cycle and thereby to contribute who were never smokers (3.71, 95% CI 1.37-10.1) and those to tumor development. As suggested by previously published who never used alcohol (4.76, 95% CI 1.61-14.0). studies, rearrangement of the 3Ј-untranslated region of CCND1 may contribute to its activation in some lymphoid tumors.
Discussion
Moreover, the finding that the half-life of CCND1 mRNA was Ͼ3 h in three cell lines (it is only 0.5 h in normal tissues) In this study we have demonstrated that the CCND1 AA stresses the importance of post-transcriptional derangement in genotype is associated with increased risk for SCCHN. The the activation of CCND1 (20). risk is more pronounced in those individuals who are younger, As one of the major genes controlling the cell cycle transition females, non-smokers and non-alcohol users. In particular, this from G 1 to S phase, abnormal CCND1 may lead to an abnormal variant genotype is associated with an early age of SSCHN cell cycle. Overexpression of CCND1 may lead to premature onset. These results are consistent with the notion that the cell passage through the G 1 /S transition, resulting in propaga-CCND1 AA genotype is a genetic susceptibility factor in tion of unrepaired DNA damage, accumulation of genetic SCCHN.
errors and a selective growth advantage for altered cells. We have previously reported an association between reduced CCND1 overexpression also appears to alter tumor cell sensit-DNA repair capacity and risk of SCCHN (16). Cell cycle control is central to repair of DNA damage before cell division ivity to ionizing radiation (21). In tumor tissues CCND1 is often overexpressed at both the transcriptional and translational
Center and by funds collected pursuant to the Comprehensive Tobacco levels (22) and its amplification or overexpression is associated Settlement of 1998 and appropriated by the 76th Legislature to the M.D.
with a more rapid and frequent recurrence of cancer (23) (24) (25) .
Anderson Cancer Center.
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